Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies…
<!-- Name:DistributionId Value:1000801022 -->
<!-- Name:NewsArchiveTags Value:MyWeb -->
<!-- Name:NewsArchiveOrgTags Value:MyWeb#My…